Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus	Recruiting	Phase 4	2026-05-05		NCT06399835

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Daewoong Pharmaceutical Co. LTD.	38
Seoul National University Bundang Hospital	114

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Seoul National University Bundang Hospital	Seongnam-si	South Korea	107

Clinical trials